Key result
Ultrasound-guided puncture of the axillary vein for cardiac device lead implantation was successful in 99.8% of 548 procedures, with low complication rates including 0.5% pneumothorax.
Why the study?
Venous access for CIED leads is commonly achieved via cephalic cutdown, blind subclavian puncture, or fluoroscopy, motivating evaluation of ultrasound-guided axillary vein puncture.
Is ultrasound-guided puncture of the axillary vein feasible, safe, and effective for the implantation of permanent leads of cardiac implantable electronic devices?
Cohort (n=548)
No
Is ultrasound-guided puncture of the axillary vein feasible, safe, and effective for the implantation of permanent leads of cardiac implantable electronic devices?
Ultrasound-guided axillary vein puncture is a highly successful and safe method for CIED lead implantation, with very low complication rates.
Answers are grounded in this paper and cite their sources.
Supports ultrasound-guided axillary access for CIED leads in observational data; leaves open randomized trials versus standard techniques.
BACKGROUND: The venous access for the insertion of permanent leads of cardiac implantable electronic devices is often achieved by venous cutdown of the cephalic vein, or by "blind" puncture of the subclavian vein using anatomical landmarks, or by fluoroscopy-assisted methods. METHODS: We have retrospectively analyzed our clinical experience to verify the feasibility, the safety, and efficacy of the adoption of ultrasound-guided puncture/cannulation of the axillary vein for this purpose. RESULTS: Nine hundred eighty-seven leads were placed during 548 consecutive procedures, accessing the axillary vein in the infraclavicular area using real-time ultrasound guidance. Venipuncture was successful in 99.8% of cases. The access time was 11 seconds (range 4-580). We recorded three cases of pneumothorax (0.5%), but no hemothorax and no hemo-mediastinum. The incidence of local hematoma was 2.1% (12 cases). No injury to the brachial plexus or to the phrenic nerve was recorded. In a follow-up of 33 months (range 16-39), we observed no cases of "subclavian crush syndrome" (damage of the leads at the level of the thoracic inlet), and the rate of pocket infection/infective endocarditis was 0.7%. CONCLUSION: In our experience, ultrasound-guided puncture/cannulation of the axillary vein for implantation of permanent leads is feasible, effective, and safe. It might be considered as a first option for this procedure.
No takes yet. Share an insight, caveat, or question.
Deluca et al. (2020) conducted a cohort in Cardiac implantable electronic device implantation (n=548). Ultrasound-guided puncture/cannulation of the axillary vein was evaluated on Venipuncture success. Ultrasound-guided puncture of the axillary vein for cardiac device lead implantation was successful in 99.8% of 548 procedures, with low complication rates including 0.5% pneumothorax.
Synapse has enriched 10 related papers. Consider them for comparative context: